PRICE T ROWE ASSOCIATES INC /MD/
Position in IDYA — IDEAYA Biosciences, Inc.
CIK 80255
BALTIMORE, MD
Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$43,844,754
-$6,252,188 QoQ
Shares Held
1,315,869
-9.2% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99.91914088712478.ToString("F0")%
Shared 0.ToString("F0")%
None 0.08085911287521783.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. IDYA ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in IDYA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,844,754 | 1,315,869 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $50,096,942 | 1,449,145 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,196,024 | 1,109,740 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,041,333 | 1,904,916 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,930,688 | 3,475,622 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $99,379,535 | 3,866,908 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $127,204,640 | 4,015,298 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $131,442,745 | 3,743,741 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $177,823,699 | 4,052,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $126,888,170 | 3,566,278 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $81,759,355 | 3,030,369 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $58,812,815 | 2,502,673 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,136,238 | 1,466,587 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $30,226,302 | 1,663,528 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $27,734,444 | 1,858,877 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,030,277 | 1,886,252 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,666,771 | 2,114,993 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $63,864,051 | 2,701,525 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $59,542,243 | 2,335,906 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $27,496,417 | 1,309,977 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $21,156,227 | 900,265 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,595,386 | 471,099 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||